“DEA will continue to support sound and scientific research that promotes legitimate therapeutic uses for FDA-approved constituent components of cannabis, consistent with federal law,” acting DEA administrator Uttam Dhillon said in a press release. “DEA is committed to continuing to work with our federal partners to seek ways to make the process for research more efficient and effective.”
Bonn-Miller also explained that it's imperative to exhaust the traditional and established front-line treatments that are available before seeking out these products. "CBD is not really a first-line treatment for anything," he said. "You don’t want situations where somebody says, 'I have cancer I'm going to forgo chemotherapy because I read something about CBD or THC helping with cancer.'" That's not a good idea, Bonn-Miller said. "Not only is the science not there, but you may end up worse off."
The information you share, including that which might otherwise be Protected Health Information, to this site is by design open to the public and is not a private, secure service. You should think carefully before disclosing any personal information in any public forum. What you have written may be seen, disclosed to, or collected by third parties and may be used by others in ways we are unable to control or predict, including to contact you or otherwise be used for unauthorized or unlawful purposes. As with any public forum on any site, this information may also appear in third-party search engines like Google, MSN, Yahoo, etc. Your use of this site is governed by Harvard University and its affiliates Terms of Use located at www.health.harvard.edu/privacy-policy and may be amended from time to time.

Multiple sclerosis (MS). There is inconsistent evidence on the effectiveness of cannabidiol for symptoms of multiple sclerosis. Some early research suggests that using a cannabidiol spray under the tongue might improve pain and muscle tightness in people with MS. However, it does not appear to improve muscle spasms, tiredness, bladder control, the ability to move around, or well-being and quality of life.


In terms of eye health, cannabis and cannabis essential oil have been linked to a reduction in glaucoma and a prevention of macular degeneration, according to a report published by Dr. John Merritt, Department of Ophthalmology School of Medicine, University of North Carolina. Eye health is one of the major reasons why people turn to cannabis essential oil as they age.
At sufficient doses (400-600 mg), CBD can alleviate situational anxiety, such as public speaking. Interestingly, cannabis cultivars, or strains, that are high in CBD and low in THC are better than other cultivars for alleviating depression. But when used over a long period of time, any kind of cannabis could make depression worse.  Although clinical trials in people haven’t yet been completed, there is very compelling “petri dish” evidence that CBD can reduce inflammation, for painful conditions such as Crohn’s disease, and fight some cancerous tumors. There is a massive amount of scientific research being done on CBD right now, and we are likely to see many medical breakthroughs in the next decade.
Are you willing to share what you're anxiety is about? I had panic and anxiety attacks for years and used Ativan and later Lorazepam for them, especially when I had to fly in planes. About 6 years ago I started taking Citalopram antidepressant, and all my anxiety/panic attacks went away. I only had it again recently during my withdrawal process. I know my relief from anxiety is from the Citalopram. I even did 7 zip lines in Costa Rica a little over a year ago. My flights there, to Panama and back were anxiety free. That has been so incredible for me! I love traveling now.
But he wasn’t finished. In February of 1980, Dr. Mechoulam teamed up with South American researchers to publish a study regarding cannabis and epilepsy. This study is seen as one of the earliest double-blind studies of CBD on clinical subjects. The study Dr. Mechoulam and his team conducted included 16 people, many of whom were children, who all suffered from severe epilepsy. The results were startling: Every subject who received CBD experienced improvement in their condition with little to no side effects. This anticonvulsant study has since proven to be an integral milestone in the world of clinical marijuana research, but largely went unnoticed at the time.

A: Mamun, Our Full spectrum CBD oil is great for assisting with pain, inflammation, sleep, anxiety and stress. Depending on the severity of the pain you are experiencing you will want to choose an oil that is stronger or weaker. 5x strength is the strongest option we have available. https://zatural.com/products/cannabis-sativa-hemp-oil-drops?variant=14337796210730
Many people may be concerned that our cannabis oils are low in THC, as compared with other cannabis extracts or concentrates (such as hash, shatter, or BHO). The most important thing to keep in mind is that it is not the potency (% or mg/mL THC) that is important, but rather the total dose in mg THC (amount of cannabis extract in mg × potency of cannabis extract % or mg/mL).
– CBD Oil with THC; This kind of oil isn’t legitimate in all states and has an unexpected impact in comparison to unadulterated CBD oil. Numerous individuals take marijuana for THC, which aids them to fight distinctive restorative conditions. They trust that when the two are joined, they give a better experience that surpasses each other’s useful properties. Note that THC can counter the advantages of CBD and in this way, perfect dosing is fundamental.
Multiple Sclerosis is a condition in which the immune system mistakenly reacts abhorrently to healthy cells and organs. Also known as an autoimmune disease, multiple sclerosis causes reoccurring spasms and enduring pain, for those affected. Although the effect is modest, CBD oil, acting as an anticonvulsant, can help in mitigating the number of spasms caused, as well as the resulting pain.
Cutting-edge science has shown that the endocannabinoid system is dysregulated in nearly all pathological conditions. Thus, it stands to reason that “modulating endocannabinoid system activity may have therapeutic potential in almost all diseases affecting humans,” as Pal Pacher and George Kunos, scientists with the U.S. National Institutes of Health (NIH), suggested in a 2014 publication.
×